Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Pilot Trial of Sorafenib, Tamoxifen and Cisplatin as Adjuvant Therapy for Patients With Stage III Malignant Melanoma

NCT00492505 is registered in ClinicalTrials.gov with San Diego Pacific Oncology & Hematology Associates as lead sponsor.

NCT NCT00492505
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00492505 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Pilot Trial of Sorafenib, Tamoxifen and Cisplatin as Adjuvant Therapy for Patients With Stage III Malignant Melanoma
Lead sponsor
San Diego Pacific Oncology & Hematology Associates
Phase
Phase 2
Overall status
Unknown status
Start date
April 30, 2007
Completion date
Not reported
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma (skin)